Coronary Revascularization

Also known as: Repeat coronary revascularization / Coronary revascularisation

DrugDrug NameDrug Description
DB06441CangrelorA P2Y12 platelet receptor antagonist used during percutaneous coronary intervention to reduce the risk for periprocedural myocardial infarction (MI), repeat coronary revascularization, and stent thrombosis (ST).
DB01394ColchicineAn alkaloid used to treat gout and Familial Mediterranean Fever as well as prevent major cardiovascular events.
DB09303EvolocumabA PCSK9 (proprotein convertase subtilisin kexin type 9) inhibitor antibody used as an adjunct to LDL cholesterol reducing therapies, aiding in the prevention of cardiovascular events and cardiovascular revascularization procedures.
DB00227LovastatinAn HMG-CoA reductase inhibitor used to lower LDL cholesterol and reduce the risk of cardiovascular disease and associated conditions, including myocardial infarction and stroke.
DrugDrug NamePhaseStatusCount
DB09303Evolocumab4Recruiting1